Lawal, B.; Tseng, S.-H.; Olugbodi, J.O.; Iamsaard, S.; Ilesanmi, O.B.; Mahmoud, M.H.; Ahmed, S.H.; Batiha, G.E.-S.; Wu, A.T.H.
Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers 2021, 13, 4124.
https://doi.org/10.3390/cancers13164124
AMA Style
Lawal B, Tseng S-H, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE-S, Wu ATH.
Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers. 2021; 13(16):4124.
https://doi.org/10.3390/cancers13164124
Chicago/Turabian Style
Lawal, Bashir, Sung-Hui Tseng, Janet Olayemi Olugbodi, Sitthichai Iamsaard, Omotayo B. Ilesanmi, Mohamed H. Mahmoud, Sahar H. Ahmed, Gaber El-Saber Batiha, and Alexander T. H. Wu.
2021. "Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance" Cancers 13, no. 16: 4124.
https://doi.org/10.3390/cancers13164124
APA Style
Lawal, B., Tseng, S. -H., Olugbodi, J. O., Iamsaard, S., Ilesanmi, O. B., Mahmoud, M. H., Ahmed, S. H., Batiha, G. E. -S., & Wu, A. T. H.
(2021). Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers, 13(16), 4124.
https://doi.org/10.3390/cancers13164124